Skip to main content

Signed · Spain · Medical technology

Hologic agrees to acquire Reveal Genomics.

Hologic, based in Marlborough, Massachusetts, signed a definitive agreement on 19 October 2026 to acquire Reveal Genomics, a Barcelona precision oncology company whose genomic tests include HER2DX for HER2-positive breast cancer. Completion is subject to Spanish regulatory approval. It was signed on 19 October 2026. It had not completed by 28 October 2026.

SigningDay 100

Signing 19 October 2026

Buyer
Hologic, Inc. ·Marlborough, United States
Target
Reveal Genomics, S.L. ·Barcelona, Spain
Type
Acquisition
Announced
19 October 2026
Signed
19 October 2026
Value
Not disclosed
People
Not stated in the release
Last checked
28 October 2026

The people side in Spain

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe